v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 20,036 $ 27,554
Restricted cash 6,000 6,000
Investments 9,886 5,928
Accounts receivable, net of allowance for doubtful accounts of $1,144 and $788, respectively 28,029 24,105
Inventory 36,774 33,183
Prepaid expenses and other assets 2,694 2,447
Total current assets 103,419 99,217
Property and equipment, net 82,392 84,667
Operating lease right-of-use assets 13,527 14,265
Intangible assets, net 6,115 5,579
Total assets 205,453 203,728
Current liabilities:    
Accounts payable and accrued expenses 22,770 28,641
Current maturities of long-term lease obligations 2,210 1,969
Total current liabilities 24,980 30,610
Long-term debt, net of debt discount and financing fees 47,938 47,496
Long-term lease obligations 18,040 19,221
Debt derivative liabilities 2,078 2,400
Other long-term liabilities 141 94
Total liabilities 93,177 99,821
Commitments and contingencies - see Note 13
Shareholders’ equity:    
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 45,765,290 and 44,148,836 shares issued and outstanding, respectively 457 441
Additional paid-in capital 406,334 394,726
Accumulated deficit (294,515) (291,260)
Total shareholders’ equity 112,276 103,907
Total liabilities and shareholders’ equity $ 205,453 $ 203,728

Source

v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Revenues $ 56,662 $ 47,912 $ 105,222 $ 89,289
Cost of goods sold 14,644 12,567 28,271 21,325
Gross profit 42,018 35,345 76,951 67,964
Costs and expenses:        
Sales and marketing 23,804 19,698 44,849 39,513
Research and development 6,853 6,658 12,944 14,066
General and administrative 9,689 9,417 19,147 19,373
Total costs and expenses 40,346 35,773 76,940 72,952
Income (loss) from operations 1,672 (428) 11 (4,988)
Other income (expense):        
Investment income 225 227 497 520
Interest expense (1,977) (2,185) (4,227) (4,512)
Change in fair value of debt derivative liabilities 480 464 322 529
Other income (expense), net 179 1 142 (105)
Total other expense, net (1,093) (1,493) (3,266) (3,568)
Net income (loss) $ 579 $ (1,921) $ (3,255) $ (8,556)
Weighted average common shares outstanding - basic (in shares) 46,063,092 43,713,313 45,605,419 43,473,541
Weighted average common shares outstanding - diluted (in shares) 47,980,830 43,713,313 45,605,419 43,473,541
Net income (loss) per common share - basic (in USD per share) $ 0.01 $ (0.04) $ (0.07) $ (0.20)
Net income (loss) per common share - diluted (in USD per share) $ 0.01 $ (0.04) $ (0.07) $ (0.20)

Source

v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (3,255) $ (8,556)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 3,385 3,177
Amortization of right-of-use assets 184 642
Amortization of intangible assets 133 138
Amortization of debt discount and deferred financing fees 442 444
Provision for bad debts 386 528
Change in fair value of debt derivative liabilities (322) (529)
Investment gains (121) (33)
Stock-based compensation 8,077 7,826
Change in operating assets and liabilities:    
Accounts receivable (4,310) (533)
Inventory (3,591) (4,995)
Prepaid expenses and other (81) 957
Accounts payable and accrued expenses (5,755) (6,577)
Operating lease obligations (542) (731)
Cash paid for interest portion of financing lease obligations (2) (2)
Other long-term liabilities (77) 143
Net cash used in operating activities (5,449) (8,101)
Cash flows from investing activities:    
Purchase of property and equipment (978) (1,834)
Purchase of investments (7,837) (1,911)
Proceeds from sale of investments 4,000 0
Cash payments for intangible assets (793) (739)
Net cash used in investing activities (5,608) (4,484)
Cash flows from financing activities:    
Cash paid for debt portion of financing lease obligations (8) (4)
Proceeds from exercise of stock options and ESPP stock purchases 3,547 752
Net cash provided by financing activities 3,539 748
Net decrease in cash and cash equivalents, and restricted cash (7,518) (11,837)
Cash and cash equivalents, and restricted cash, beginning of period 33,554 37,026
Cash and cash equivalents, and restricted cash, end of period 26,036 25,189
Supplemental disclosures of cash flow activity:    
Cash paid for interest 3,559 3,758
Supplemental disclosure of noncash investing and financing activities:    
Acquisition of property and equipment change in accounts payable and accrued expenses 132 178
Acquisition of intangible assets change in accounts payable and accrued expenses $ (124) $ 242

Source